Pentoxifylline inhibits intercellular adhesion molecule-1 (ICAM-1) and lung injury in experimental phosgene-exposure rats

References

• Abraham E. 2003. Neutrophils and acute lung injury. Crit Care Med 31:S195–S199.
   PubMed Web of Science ®Google Scholar
• Akgür FM, Zibari GB, McDonald JC, Granger DN, Brown MF. 1999. Effects of dextran and pentoxifylline on hemorrhagic shock-induced P-selectin expression. J Surg Res 87:232–238.
   PubMedGoogle Scholar
• Albelda SM, Smith CW, Ward PA. 1994. Adhesion molecules and inflammatory injury. FASEB J 8:504–512.
   PubMed Web of Science ®Google Scholar
• Aldridge AJ. 2002. Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surg 168:204–214.
   PubMedGoogle Scholar
• Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R, Suter PM. 1998. The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med 24:378–398.
   PubMed Web of Science ®Google Scholar
• Balázs C, Kiss E. 1994. Immunological aspects of the effect of pentoxifylline (Trental) (a brief review). Acta Microbiol Immunol Hung 41:121–126.
   PubMedGoogle Scholar
• Bella J, Kolatkar PR, Marlor CW, Greve JM, Rossmann MG. 1999. The structure of the two amino-terminal domains of human intercellular adhesion molecule-1 suggests how it functions as a rhinovirus receptor. Virus Res 62:107–117.
   PubMed Web of Science ®Google Scholar
• Bessler H, Gilgal R, Djaldetti M, Zahavi I. 1986. Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol 40:747–754.
   PubMed Web of Science ®Google Scholar
• Betsuyaku T, Nishimura M, Takeyabu K, Tanino M, Venge P, Xu S, Kawakami Y. 1999. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 159:1985–1991.
   PubMed Web of Science ®Google Scholar
• Bhatia M, Moochhala S. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202:145–156.
   PubMed Web of Science ®Google Scholar
• Boerma M, Roberto KA, Hauer-Jensen M. 2008. Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. Int J Radiat Oncol Biol Phys 72:170–177.
   PubMed Web of Science ®Google Scholar
• Borak J, Diller WF. 2001. Phosgene exposure: mechanisms of injury and treatment strategies. J Occup Environ Med 43:110–119.
   PubMed Web of Science ®Google Scholar
• Crouch SP, Fletcher J. 1992. Effect of ingested pentoxifylline on neutrophil superoxide anion production. Infect Immun 60:4504–4509.
   PubMed Web of Science ®Google Scholar
• Currie MS, Rao KM, Padmanabhan J, Jones A, Crawford J, Cohen HJ. 1990. Stimulus-specific effects of pentoxifylline on neutrophil CR3 expression, degranulation, and superoxide production. J Leukoc Biol 47:244–250.
   PubMed Web of Science ®Google Scholar
• de Campos T, Deree J, Martins JO, Loomis WH, Shenvi E, Putnam JG, Coimbra R. 2008. Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis. Pancreas. 37:42–49.
   PubMedGoogle Scholar
• D’Hellencourt CL, Diaw L, Cornillet P, Guenounou M. 1996. Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline. Int J Immunopharmacol 18:739–748.
   PubMedGoogle Scholar
• Diller WF. 1985. Pathogenesis of phosgene poisoning. Toxicol Ind Health 1:7–15.
   PubMedGoogle Scholar
• Doggenweiler CF, Frenk S. 1965. Staining properties of lanthanum on cell membranes. Proc Natl Acad Sci USA 53:425–427.
   PubMed Web of Science ®Google Scholar
• Domínguez-Jiménez C, Sancho D, Nieto M, Montoya MC, Barreiro O, Sánchez-Madrid F, González-Amaro R. 2002. Effect of pentoxifylline on polarization and migration of human leukocytes. J Leukoc Biol 71:588–596.
   PubMed Web of Science ®Google Scholar
• Folch-Puy E. 2007. [Markers of severity in acute pancreatitis]. Med Clin (Barc) 128:417–418.
   PubMedGoogle Scholar
• Golias C, Tsoutsi E, Matziridis A, Makridis P, Batistatou A, Charalabopoulos K. 2007. Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. In Vivo 21:757–769.
   PubMed Web of Science ®Google Scholar
• Grainge C, Brown R, Jugg BJ, Smith AJ, Mann TM, Jenner J, Rice P, Parkhouse DA. 2009. Early treatment with nebulised salbutamol worsens physiological measures and does not improve survival following phosgene induced acute lung injury. J R Army Med Corps 155:105–109.
   PubMedGoogle Scholar
• Gray KD, Simovic MO, Chapman WC, Blackwell TS, Christman JW, May AK, Parman KS, Stain SC. 2003. Endotoxin potentiates lung injury in cerulein-induced pancreatitis. Am J Surg 186:526–530.
   PubMedGoogle Scholar
• Hammerschmidt DE, Kotasek D, McCarthy T, Huh PW, Freyburger G, Vercellotti GM. 1988. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor. J Lab Clin Med 112:254–263.
   PubMed Web of Science ®Google Scholar
• Han J, Huez G, Beutler B. 1991. Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. J Immunol 146:1843–1848.
   PubMed Web of Science ®Google Scholar
• Helenmae Clark Robert, J, Gorlin D. 1958. On the use of a modified fifteen-minute hematoxylin and eosin tissue stain. Oral Surgery, Oral Medicine, Oral Pathology.11: 431–432.
   PubMedGoogle Scholar
• Heller S, Weber K, Heller A, Urbaschek R, Koch T. 1999. Pentoxifylline improves bacterial clearance during hemorrhage and endotoxemia. Crit Care Med 27:756–763.
   PubMed Web of Science ®Google Scholar
• Hill J, Lindsay T, Valeri CR, Shepro D, Hechtman HB. 1993. A CD18 antibody prevents lung injury but not hypotension after intestinal ischemia-reperfusion. J Appl Physiol 74:659–664.
   PubMedGoogle Scholar
• Huang Q, Shao L, He M, Chen H, Liu D, Luo Y, Dai Y. 2005. Inhibitory effects of sasanquasaponin on over-expression of ICAM-1 and on enhancement of capillary permeability induced by burns in rats. Burns 31:637–642.
   PubMedGoogle Scholar
• Inoue S, Nakao A, Kishimoto W, Murakami H, Harada A, Nonami T, Takagi H. 1996. LFA-1 (CD11a/CD18) and ICAM-1 (CD54) antibodies attenuate superoxide anion release from polymorphonuclear leukocytes in rats with experimental acute pancreatitis. Pancreas 12:183–188.
   PubMedGoogle Scholar
• Lee WL, Downey GP. 2001. Neutrophil activation and acute lung injury. Curr Opin Crit Care 7:1–7.
   PubMedGoogle Scholar
• Li WL, Hai CX, Liang X, Zhang XD, Chen HL, Qin XJ, Liu R, He W, Wang P, Li B. 2006. Apoptosis of ATII cells in mice induced by phosgene. Inhal Toxicol 18:71–77.
   PubMed Web of Science ®Google Scholar
• Marcus BC, Hynes KL, Gewertz BL. 1997. Loss of endothelial barrier function requires neutrophil adhesion. Surgery 122:420–6; discussion 426.
   PubMed Web of Science ®Google Scholar
• Matthay MA, Martin TR. 2005. Pulmonary edema and acute lung injury, In: Mason (Ed.), Murray & Nadel’s Textbook of Respiratory Medicine, 4th ed. Saunders.
   Google Scholar
• National Toxicology Program. 2001. Chemical health and safety data. http://ntp-server.niehs.nih.gov/Main Pages/Chem-HS.html.
   Google Scholar
• Parsey MV, Tuder RM, Abraham E. 1998. Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J Immunol 160:1007–1013.
   PubMed Web of Science ®Google Scholar
• Rao KM, Crawford J, Currie MS, Cohen HJ. 1988. Actin depolymerization and inhibition of capping induced by pentoxifylline in human lymphocytes and neutrophils. J Cell Physiol 137:577–582.
   PubMed Web of Science ®Google Scholar
• Russell D, Blain PG, Rice P. 2006. Clinical management of casualties exposed to lung damaging agents: a critical review. Emerg Med J 23:421–424.
   PubMed Web of Science ®Google Scholar
• Schneider W, Diller W. 1989. Phosgene. In: Ullmann’s Encyclopedia of industrial chemistry. 5th ed. Vol. A 19:411–420. Weinheim, Germany: VCH Verlag.
   Google Scholar
• Sciuto AM, Hurt HH. 2004. Therapeutic treatments of phosgene-induced lung injury. Inhal Toxicol 16:565–580.
   PubMed Web of Science ®Google Scholar
• Sciuto AM. 2000. Posttreatment with ETYA protects against phosgene-induced lung injury by amplifying the glutathione to lipid peroxidation ratio. Inhal Toxicol 12:347–356.
   PubMed Web of Science ®Google Scholar
• Sciuto AM, Stotts RR, Hurt HH. 1996. Efficacy of ibuprofen and pentoxifylline in the treatment of phosgene-induced acute lung injury. J Appl Toxicol 16:381–384.
   PubMed Web of Science ®Google Scholar
• Seiffge D, Bissinger T, Kremer E, Laux V, Schleyerbach R. 1995. Inhibitory effects of pentoxifylline on LPS-induced leukocyte adhesion and macromolecular extravasation in the microcirculation. Inflamm Res 44:281–286.
   PubMed Web of Science ®Google Scholar
• Shenkar R, Abraham E. 1999. Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. J Immunol 163:954–962.
   PubMed Web of Science ®Google Scholar
• Smith A, Brown R, Jugg B, Platt J, Mann T, Masey C, Jenner J, Rice P. 2009. The effect of steroid treatment with inhaled budesonide or intravenous methylprednisolone on phosgene-induced acute lung injury in a porcine model. Mil Med 174:1287–1294.
   PubMed Web of Science ®Google Scholar
• Strohschneider T, Kling D, Betz E. 1988. The effect of pentoxifylline on endothelial permeability of rabbit carotid artery wall. Eur J Pharmacol 150:287–293.
   PubMedGoogle Scholar
• Sullivan GW, Carper HT, Novick WJ Jr, Mandell GL. 1988. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun 56:1722–1729.
   PubMed Web of Science ®Google Scholar
• Szinicz L. 2005. History of chemical and biological warfare agents. Toxicology 214:167–181.
   PubMed Web of Science ®Google Scholar
• Teresa Krakauer. 2000. Pentoxifylline inhibits ICAM-1 expression and chemokine production induced by proinflammatory cytokines in human pulmonary epithelial cells. Immunopharmacology. 46:253–261.
   PubMedGoogle Scholar
• Torkunov PA, Shabanov PD. 2009. [Using NO-synthase inhibitors derived from L-arginine for preventing acute experimental lung edema development in mice]. Eksp Klin Farmakol 72:44–46.
   PubMedGoogle Scholar
• Torkunov PA, Zemlianoi AV, Shabanov PD. 2007. [Antiedematous effect of diphenyliodinium salts on experimental toxic lung edema]. Eksp Klin Farmakol 70:36–40.
   PubMedGoogle Scholar
• van de Stolpe A, van der Saag PT. 1996. Intercellular adhesion molecule-1. J Mol Med 74:13–33.
   PubMed Web of Science ®Google Scholar
• Voisin L, Breuillé D, Ruot B, Rallière C, Rambourdin F, Dalle M, Obled C. 1998. Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats. Am J Physiol 275:R1412–R1419.
   PubMedGoogle Scholar
• Ware LB, Matthay MA. 2000. The acute respiratory distress syndrome. N Engl J Med 342:1334–1349.
   PubMed Web of Science ®Google Scholar
• Weinberg JB, Mason SN, Wortham TS. 1992. Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: dissociation of acivicin-induced TNF-alpha and IL-1 beta mRNA expression from acivicin-induced monocytoid differentiation. Blood 79:3337–3343.
   PubMed Web of Science ®Google Scholar
• Zhang XD, Hai CX, Cai FL, Liang X, Liu R, Chen HL, Qin XJ, Feng AJ. 2008. Time course for expression of VEGF and its receptor and regulator levels of contraction and relaxation in increased vascular permeability of lung induced by phosgene. Inhal Toxicol 20:805–812.
   PubMed Web of Science ®Google Scholar